Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 3Uterine Anomalies 1Salpingitis 1Prostatic Neoplasms 1Progesterone Resistance 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Obesity 1Leiomyoma 1Infertility, Female 1Infertility 1Hypertension 1Endometritis 1Endometriosis 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

ulipristal acetate 12Uterine Myomectomy 10Uterine Artery Embolization 7Bupivacaine 7Tranexamic Acid 6Leuprolide 6Saline Solution 5Mifepristone 5Letrozole 4Hysterectomy 4epigallocatechin gallate 3Surveys and Questionnaires 3Sodium Chloride 3Misoprostol 3Lidocaine 3Hysteroscopy 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3ulipristal 2cetrorelix 2Vitamin B 6 2Tea 2Tablets 2Radiofrequency Ablation 2Observation 2Goserelin 2Gonadotropins 2Chorionic Gonadotropin 2Anesthesia, Obstetrical 2Anesthesia, General 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leiomyoma × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × Clear all
NCT04071574 2023-05-09

CS-EOSP-ICSI

Lebanese University

Phase 1/2 Completed
200 enrolled
Gynecologic

Uterine Anomalies, Endometriosis, Endometritis, Infertility, Infertility, Female, Leiomyoma, Polycystic Ovary Syndrome, Pregnancy, Ectopic, Salpingitis, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡